144 related articles for article (PubMed ID: 27494686)
1. Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generation.
Cheng Q; Wang Z; Ma R; Chen Y; Yan Y; Miao S; Jiao J; Cheng X; Kong L; Ye D
Int Immunopharmacol; 2016 Oct; 39():229-235. PubMed ID: 27494686
[TBL] [Abstract][Full Text] [Related]
2. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
[TBL] [Abstract][Full Text] [Related]
3. Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis.
Walker J; Dichter E; Lacorte G; Kerner D; Spur B; Rodriguez A; Yin K
Shock; 2011 Oct; 36(4):410-6. PubMed ID: 21701419
[TBL] [Abstract][Full Text] [Related]
4. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.
Moreno C; Prieto P; Macías Á; Pimentel-Santillana M; de la Cruz A; Través PG; Boscá L; Valenzuela C
J Immunol; 2013 Dec; 191(12):6136-46. PubMed ID: 24249731
[TBL] [Abstract][Full Text] [Related]
5. Lipoxin A4 suppresses lipopolysaccharide-induced hela cell proliferation and migration via NF-κB pathway.
Hao H; Xu F; Hao J; He YQ; Zhou XY; Dai H; Wu LQ; Liu FR
Inflammation; 2015 Feb; 38(1):400-8. PubMed ID: 25348861
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways.
Tylek K; Trojan E; Leśkiewicz M; Regulska M; Bryniarska N; Curzytek K; Lacivita E; Leopoldo M; Basta-Kaim A
Cells; 2021 Sep; 10(9):. PubMed ID: 34572022
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.
Kure I; Nishiumi S; Nishitani Y; Tanoue T; Ishida T; Mizuno M; Fujita T; Kutsumi H; Arita M; Azuma T; Yoshida M
J Pharmacol Exp Ther; 2010 Feb; 332(2):541-8. PubMed ID: 19846590
[TBL] [Abstract][Full Text] [Related]
8. Regulation of aquaporin 4 expression by lipoxin A4 in astrocytes stimulated by lipopolysaccharide.
Wu J; Ding D; Wang X; Li Q; Sun Y; Li L; Wang Y
Cell Immunol; 2019 Oct; 344():103959. PubMed ID: 31383359
[TBL] [Abstract][Full Text] [Related]
9. Lipoxin A(4) promotes more complete inflammation resolution in sepsis compared to stable lipoxin A(4) analog.
Wu B; Walker JA; Temmermand D; Mian K; Spur B; Rodriguez A; Stein TP; Banerjee P; Yin K
Prostaglandins Leukot Essent Fatty Acids; 2013 Jul; 89(1):47-53. PubMed ID: 23688707
[TBL] [Abstract][Full Text] [Related]
10. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
Marginean A; Sharma-Walia N
Transl Res; 2015 Aug; 166(2):111-33. PubMed ID: 25814167
[TBL] [Abstract][Full Text] [Related]
11. [Effect of lipoxin A4 on the expression of Toll-like receptor 4 and TNF receptor-associated factor 6 in the liver of obese rats with sepsis].
Jiang WW; Gao LL; Wu M; Zhao T; Shen DL
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):578-584. PubMed ID: 30022762
[TBL] [Abstract][Full Text] [Related]
12. Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway.
Yuan J; Lin F; Chen L; Chen W; Pan X; Bai Y; Cai Y; Lu H
Inflammopharmacology; 2022 Apr; 30(2):487-498. PubMed ID: 35235107
[TBL] [Abstract][Full Text] [Related]
13. Lipid mediator lipoxin A4 inhibits tumor growth by targeting IL-10-producing regulatory B (Breg) cells.
Wang Z; Cheng Q; Tang K; Sun Y; Zhang K; Zhang Y; Luo S; Zhang H; Ye D; Huang B
Cancer Lett; 2015 Aug; 364(2):118-24. PubMed ID: 25979229
[TBL] [Abstract][Full Text] [Related]
14. Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator.
Xu Z; Zhao F; Lin F; Xiang H; Wang N; Ye D; Huang Y
Fertil Steril; 2014 Jul; 102(1):282-290.e4. PubMed ID: 24796762
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*.
Ueda T; Fukunaga K; Seki H; Miyata J; Arita M; Miyasho T; Obata T; Asano K; Betsuyaku T; Takeda J
Crit Care Med; 2014 Apr; 42(4):e288-95. PubMed ID: 24463858
[TBL] [Abstract][Full Text] [Related]
16. Lipoxin A
Gaudin A; Tolar M; Peters OA
Sci Rep; 2018 Jun; 8(1):8921. PubMed ID: 29892010
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.
Colby JK; Gott KM; Wilder JA; Levy BD
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):25-33. PubMed ID: 26039320
[TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell-Mediated Generation of LXA4.
Ke Y; Zebda N; Oskolkova O; Afonyushkin T; Berdyshev E; Tian Y; Meng F; Sarich N; Bochkov VN; Wang JM; Birukova AA; Birukov KG
Circ Res; 2017 Jul; 121(3):244-257. PubMed ID: 28522438
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
Sato Y; Kitasato H; Murakami Y; Hashimoto A; Endo H; Kondo H; Inoue M; Hayashi I
Biomed Pharmacother; 2004; 58(6-7):381-7. PubMed ID: 15271420
[TBL] [Abstract][Full Text] [Related]
20. Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury.
Lv W; Lv C; Yu S; Yang Y; Kong H; Xie J; Sun H; Andersson R; Xu D; Chen B; Zhou M
Exp Biol Med (Maywood); 2013 Dec; 238(12):1388-95. PubMed ID: 24000382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
